News
Frequent monitoring of blood counts is required while on therapy. Initial treatment of CML patients with hydroxyurea is usually a daily dose of 1-4 grams, depending on the white blood count ...
2mon
The Brighterside of News on MSNNew discovery revolutionizes blood cancer treatmentMillions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...
Panelists discuss how chronic myeloid leukemia (CML) treatment has evolved over the past 5 years, highlighting advancements in tyrosine kinase inhibitor (TKI) therapy, improved adverse effect ...
Panelists discuss how eliminating the strict mealtime restrictions with the new nilotinib formulation addresses a significant unmet need in chronic myeloid leukemia (CML) treatment by reducing ...
When I started volunteering with Relay For Life in 2009, I had no idea how personal my connection to the cause would become.
2006). These are impressive numbers. Given this success rate, many people say that Gleevec has transformed CML treatment. In the past, the only options patients had were either bone marrow ...
Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.
Cancer Research UK granted £3.1m (nearly $4m) to a group of researchers at the University of Glasgow to enable a pioneering study to help find new treatments for CML - chronic myeloid leukaemia.
Digital PCR was therefore more sensitive and more accurate, allowing a reliable measurement to select CML patients in deep remission eligible for drug treatment discontinuation." BCR::ABL1 is a ...
Digital PCR was therefore more sensitive and more accurate, allowing a reliable measurement to select CML patients in deep remission eligible for drug treatment discontinuation." BCR::ABL1 is a ...
Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results